- Home
- OSW vs ZLAB Comparison
OSW vs ZLAB Comparison
Compare OSW & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OSW | ZLAB |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | Bahamas | China |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.6B |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | OSW | ZLAB |
|---|---|---|
| Price | $30.63 | $24.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 12 |
| Target Price | $33.00 | ★ $34.13 |
| AVG Volume (30 Days) | 990.5K | ★ 1.1M |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | N/A | ★ 38.46 |
| EPS | ★ 0.71 | N/A |
| Revenue | ★ $961,001,000.00 | $460,156,000.00 |
| Revenue This Year | $7.96 | N/A |
| Revenue Next Year | $8.79 | $22.41 |
| P/E Ratio | $43.20 | ★ N/A |
| Revenue Growth | 7.37 | ★ 15.33 |
| 52 Week Low | $19.06 | $15.96 |
| 52 Week High | $33.05 | $29.02 |
Technical Indicators
Market Signals| Indicator | OSW | ZLAB |
|---|---|---|
| Relative Strength Index (RSI) | 66.97 | 50.60 |
| Support Level | $23.22 | $24.24 |
| Resistance Level | N/A | $26.64 |
| Average True Range (ATR) | 1.24 | 1.29 |
| MACD | 0.10 | 0.35 |
| Stochastic Oscillator | 74.07 | 40.61 |
Price Performance
Historical ComparisonAbout OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.